ZIMBABWE has officially launched the long-acting HIV prevention injection lenacapavir, with the United States pledging to ...

Zimbabwe's health authorities began administering the long-acting HIV prevention drug lenacapavir, making the country one of ...

Lab technician Xolile Mhlanga works on lenacapavir at the Desmond Tutu Health Foundation's Masiphumelele Research Site, in ...

By Chris Takudzwa Muronzi HARARE, Feb 19 (Reuters) - Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented ...

Zimbabwe is one of the first countries to introduce the HIV prevention drug lenacapavir. The program aims to target over 46,000 high-risk individuals, backed by U.S. funding and the Global Fund.

Starting between April and June this year, Lenacapavir a six-month HIV prevention injection will become available at over 300 ...

Kenya received its first batch of 21,000 doses on Tuesday through a deal with lenacapavir's manufacturer, Gilead Sciences, ...

South Africa will launch Lenacapavir, a six-month HIV prevention injection, in six provinces, targeting all HIV-negative individuals to curb new infections.

Zimbabwe is now one of the first countries in the world to start a lenacapavir program, which was made possible through funding from the United States government and The Global Fund.

The first shipment of Lenacapavir, a new HIV prevention treatment, landed in the country on Tuesday night.The delivery was confirmed by the US Embassy Nairobi, which said the medicine could sharply ...

Kenya has received 21,000 doses of the long-acting HIV prevention injection Lenacapavir, with rollout set to begin in March.